Local Health News and Alerts

Long COVID & Post-Viral Conditions

Long COVID in 2026: Fatigue, Prevention, and Higher-Risk Groups
June 2, 2026 2:07 pm

New CDC guidance and fresh research reinforce the same core message: long COVID can follow even a mild infection, normal tests do not rule it out, and the best proven way to lower risk is still reducing the chances of severe COVID-19. Early studies on fatigue treatments and supplements are interesting, but they are not yet practice-changing. New U.S. data also suggest long COVID still falls unevenly across communities, which matters for access to diagnosis and care.

Read More Long COVID in 2026: Fatigue, Prevention, and Higher-Risk Groups
Rare Diseases & Orphan Drugs

FDA’s rare-disease approval push could widen access for ultra-rare therapies
June 2, 2026 2:07 pm

The FDA says it wants to make room for individualized treatments in ultra-rare diseases without lowering the bar for evidence. A new draft framework, plus several 2026 approvals, shows how regulators are trying to balance flexibility with proof that a therapy targets the disease’s root cause.

Read More FDA’s rare-disease approval push could widen access for ultra-rare therapies
Maternal & Infant Health

FDA’s New Pregnancy-Safety Guidance Could Improve Medicine Data
June 2, 2026 2:07 pm

The FDA has finalized new guidance on collecting pregnancy-safety data after a drug or biologic is approved. The change will not rewrite labels overnight, but it could strengthen the evidence doctors and patients rely on when deciding whether medicine is needed during pregnancy.

Read More FDA’s New Pregnancy-Safety Guidance Could Improve Medicine Data
Chronic Disease Prevention

Earlier LDL lowering for primary prevention: what new evidence changes
June 2, 2026 2:07 pm

New 2026 research adds momentum to earlier LDL lowering for people without prior heart attack or stroke. But the basics have not changed: healthy habits, blood pressure control, cholesterol screening, and statins remain the mainstay for most primary prevention decisions.

Read More Earlier LDL lowering for primary prevention: what new evidence changes
Screening & Prevention Guidelines

Should breast screening depend on risk instead of age?
June 2, 2026 2:07 pm

A large randomized trial suggests breast cancer screening can be tailored by risk without missing more advanced cancers compared with standard screening. But U.S. guidance has not broadly shifted yet, and experts still see important limits in the evidence.

Read More Should breast screening depend on risk instead of age?
Clinical Trials

FDA’s real-time clinical trial push could change how results are reported
June 2, 2026 2:07 pm

The FDA is testing a faster way to view some trial data as studies are running while also pressing sponsors to catch up on overdue results reports. The big takeaway for readers: this is a change in transparency and timing, not proof that a therapy works.

Read More FDA’s real-time clinical trial push could change how results are reported
Medical Research & Studies

FDA Pregnancy-Safety Guidance Aims to Improve Drug Data
June 2, 2026 2:07 pm

The FDA has finalized guidance meant to help sponsors collect better pregnancy safety data after a drug or biologic is approved. The goal is not to label any one medicine safer or riskier on its own, but to improve the evidence doctors and patients can use later.

Read More FDA Pregnancy-Safety Guidance Aims to Improve Drug Data
Medical Research & Clinical Studies

FDA guidance aims to improve pregnancy safety data after approval
June 2, 2026 2:07 pm

The FDA has finalized guidance meant to help drug and biologic makers study pregnancy safety after a product is approved. For patients, the practical message is simple: this does not change prescriptions by itself, and it does not prove a medicine is safe or unsafe in pregnancy.

Read More FDA guidance aims to improve pregnancy safety data after approval
Long COVID & Post-Viral Conditions

Long COVID in 2026: CDC says normal tests don’t rule it out
June 2, 2026 2:07 pm

CDC’s updated Long COVID guidance keeps the focus on symptoms, function, and follow-up care. The key takeaway for readers is simple: a normal lab workup does not automatically rule out Long COVID.

Read More Long COVID in 2026: CDC says normal tests don’t rule it out
Rare Diseases & Orphan Drugs

FDA’s Menkes Approval Raises Newborn Screening Questions
June 2, 2026 2:07 pm

A new FDA-approved treatment for Menkes disease raises the stakes for early diagnosis. The hard part now is whether newborn screening systems can find ultra-rare disorders fast enough, accurately enough, and fairly enough to help babies in time.

Read More FDA’s Menkes Approval Raises Newborn Screening Questions
Maternal & Infant Health

Pregnancy RSV shots: what the newest CDC data say about uptake, timing, and safety
June 2, 2026 2:07 pm

CDC’s latest coverage dashboard shows that many pregnant people still have not chosen an RSV prevention strategy. The practical question is still timing: maternal Abrysvo in late pregnancy or infant nirsevimab after birth.

Read More Pregnancy RSV shots: what the newest CDC data say about uptake, timing, and safety
Chronic Disease Prevention

New blood pressure monitoring evidence may catch hidden hypertension earlier
June 2, 2026 2:06 pm

A new 2026 review is putting more attention on blood pressure checks done at home and other settings outside the doctor’s office. Those readings can sometimes spot masked high blood pressure or rule out a one-time office spike, which may help prevention efforts. The takeaway is practical: home monitoring can add useful information, but it works best with the right device, proper technique, and follow-up with a clinician.

Read More New blood pressure monitoring evidence may catch hidden hypertension earlier
Chronic Disease Prevention

What the New 2025–2026 Blood Pressure Guidance Means for Prevention
June 2, 2026 2:06 pm

A recent hypertension guidance update puts more emphasis on accurate blood-pressure measurement, repeated confirmation, home monitoring, and risk-based prevention. For many adults, the practical takeaway is not a new alarm bell, but a clearer plan for when lifestyle steps, follow-up, and medication may come into play.

Read More What the New 2025–2026 Blood Pressure Guidance Means for Prevention
Screening & Prevention Guidelines

Could Type 1 Diabetes Screening Catch the Disease Earlier?
June 2, 2026 2:06 pm

The CDC has added a new screening page that brings a once mostly specialist idea into a more public-facing conversation: type 1 diabetes can begin before symptoms, and some people at higher risk may be identified earlier with a blood test. That matters because many people still learn they have type 1 diabetes only after a medical emergency such as diabetic ketoacidosis.

Read More Could Type 1 Diabetes Screening Catch the Disease Earlier?
Clinical Trials

Can a Team-Based Blood Pressure Program Help Low-Income Patients?
June 2, 2026 2:06 pm

A new NIH-backed clinical trial suggests the answer may be yes. In federally qualified health centers, a care model built around home monitoring, coaching, and faster medication adjustments lowered blood pressure more than enhanced usual care over 18 months — but it is a care strategy, not a new drug, and questions remain about cost, scale, and long-term outcomes.

Read More Can a Team-Based Blood Pressure Program Help Low-Income Patients?
Medical Research & Studies

CDC’s new Long COVID guidance says symptoms deserve care
June 2, 2026 2:06 pm

The CDC updated its Long COVID clinical guidance on March 9, 2026, with a practical message for patients and clinicians: persistent symptoms can be evaluated even when routine tests look normal. The agency says care should focus on the person’s history, exam, symptoms, and function—not on waiting for one test to “prove” Long COVID.

Read More CDC’s new Long COVID guidance says symptoms deserve care
Medical Research & Clinical Studies

Long COVID still disrupts daily life as 2026 studies sharpen the picture
June 2, 2026 2:06 pm

CDC’s March 2026 updates reinforce a cautious message: Long COVID is real, testing is still imperfect, and treatment evidence remains limited. New research adds clues about symptoms and possible risks, but it does not yet point to a single proven fix.

Read More Long COVID still disrupts daily life as 2026 studies sharpen the picture
Long COVID & Post-Viral Conditions

Can a COVID booster still help lower long COVID risk in 2026?
June 2, 2026 2:06 pm

A COVID booster may still lower the chance of long COVID, but it is not a guarantee. The latest CDC guidance says vaccination remains the best available tool to prevent long COVID, while newer studies suggest protection that is real but not complete.

Read More Can a COVID booster still help lower long COVID risk in 2026?
Rare Diseases & Orphan Drugs

FDA’s Menkes approval highlights how narrow early treatment can be
June 2, 2026 2:06 pm

The FDA has approved the first treatment for children with Menkes disease, a rare and often severe genetic disorder that starts in infancy. The bigger story is how quickly the disease can cause harm — and why faster diagnosis may matter as much as treatment itself.

Read More FDA’s Menkes approval highlights how narrow early treatment can be
Maternal & Infant Health

What New CDC Data and 2026 Guidance Mean for RSV Protection in Pregnancy
June 2, 2026 2:06 pm

CDC and ACOG say families now have two main ways to protect babies from RSV: maternal vaccination during the right pregnancy window or an antibody product for the infant. New CDC surveillance suggests many babies still miss protection, often when clinicians do not clearly recommend it.

Read More What New CDC Data and 2026 Guidance Mean for RSV Protection in Pregnancy
Chronic Disease Prevention

Should you ask for a one-time Lp(a) cholesterol test?
June 2, 2026 2:06 pm

A March 2026 heart guideline says adults should have lipoprotein(a), or Lp(a), measured at least once as part of cardiovascular risk assessment. That does not mean everyone needs urgent testing, but it does give many adults a reason to ask whether this separate blood test has ever been done.

Read More Should you ask for a one-time Lp(a) cholesterol test?
Screening & Prevention Guidelines

Can You Collect Your Own Cervical Screening Sample? What ACOG’s 2026 Update Means
June 2, 2026 2:06 pm

ACOG’s April 23, 2026 update backs patient-collected high-risk HPV screening as an option for some average-risk adults ages 30 to 65. Here’s who it may fit, what it does not replace, how follow-up works, and when most insurance coverage is expected to change.

Read More Can You Collect Your Own Cervical Screening Sample? What ACOG’s 2026 Update Means

End of content